3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
16
Colorectal Neoplasms
14
Neoplasms
12
Hematopoietic and Lymphatic System Neoplasm
12
Lung Neoplasms
9
Hematologic Neoplasms
8
Ovarian Neoplasms
5
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Lymphoma
4
Urinary Bladder Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Endometrial Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Interviews as Topic
×
1 year
×
Clear all
No trials found.